Remove Biosimilars Remove Department of Veterans Affairs Related Topics
article thumbnail

Go-To-Patient Strategy- 2033

PharmaState Academy

Department of Veterans Affairs found that “patients’ health outcomes improve when physicians individualize care and take their patients’ life circumstances into account.” In the coming age of biopharmaceuticals and biosimilars, every patient will have different needs, especially young patients with life-style disease problems.